No takes yet. Share an insight, caveat, or question.
Translational study demonstrates that the IL-33/IL-5/Foxp3 axis aggravates acute graft-versus-host disease in stem cell recipients and mice, highlighting a novel therapeutic target.
Zhu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: